The Gut Microbiome and Colorectal Cancer: An Integrative Review of the Underlying Mechanisms

Overview

Journal Cell Biochem Biophys

Specialties Biochemistry
Biophysics
Cell Biology

Date 2025 Feb 13

PMID 39946032

Authors

Farah Karam

Yara El Deghel

Rabah Iratni

Ali H Dakroub

Ali H Eid

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide. While the incidence and mortality of CRC have decreased overall due to better screening, rates in adults under 50 have risen. CRC can manifest as inherited syndromes (10%), familial clustering (20%), or sporadic forms (70%). The gut microbiota, comprising mainly firmicutes and bacteroidetes, play a key role in CRC development and prevention. Indeed, CRC progression is influenced by the dynamic interaction between the gut microbiota, the intestinal barrier, the immune system, and the production of short-chain fatty acids. Not surprisingly, imbalance in the gut microbiota, termed dysbiosis, has been linked to CRC due to ensuing chronic inflammation, DNA damage, and oxidative stress. This may explain the notion that probiotics and fecal microbiota transplantation offer potential strategies for CRC prevention and treatment by restoring microbial balance and enhancing anti-cancer immune responses. This review appraises the roles of gut microbiota in promoting or preventing CRC. It also discusses the mechanistic interplay between microbiota composition, the intestinal barrier, and the immune system, with the hope of developing potential therapeutic strategies.

References

Mattiuzzi C, Sanchis-Gomar F, Lippi G . Concise update on colorectal cancer epidemiology. Ann Transl Med. 2020; 7(21):609. PMC: 7011596. DOI: 10.21037/atm.2019.07.91. View

Alzahrani S, Al Doghaither H, Al-Ghafari A . General insight into cancer: An overview of colorectal cancer (Review). Mol Clin Oncol. 2021; 15(6):271. PMC: 8591689. DOI: 10.3892/mco.2021.2433. View

Danial D, Youssef E, Maryam B, Mohammad A, Moein B, Liliane D . Risk Factors of Young-Onset Colorectal Cancer: Analysis of a Large Population-Based Registry. Can J Gastroenterol Hepatol. 2022; 2022:3582443. PMC: 8866030. DOI: 10.1155/2022/3582443. View

Siegel R, Wagle N, Cercek A, Smith R, Jemal A . Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023; 73(3):233-254. DOI: 10.3322/caac.21772. View

Gryfe R . Inherited colorectal cancer syndromes. Clin Colon Rectal Surg. 2010; 22(4):198-208. PMC: 2796102. DOI: 10.1055/s-0029-1242459. View

Boland C, Goel A . Microsatellite instability in colorectal cancer. Gastroenterology. 2010; 138(6):2073-2087.e3. PMC: 3037515. DOI: 10.1053/j.gastro.2009.12.064. View

Pino M, Chung D . The chromosomal instability pathway in colon cancer. Gastroenterology. 2010; 138(6):2059-72. PMC: 4243705. DOI: 10.1053/j.gastro.2009.12.065. View

Nolano A, Medugno A, Trombetti S, Liccardo R, De Rosa M, Izzo P . Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome. Cancers (Basel). 2023; 15(1). PMC: 9817772. DOI: 10.3390/cancers15010075. View

Kuipers E, Grady W, Lieberman D, Seufferlein T, Sung J, Boelens P . Colorectal cancer. Nat Rev Dis Primers. 2016; 1:15065. PMC: 4874655. DOI: 10.1038/nrdp.2015.65. View

10.

Kasi A, Handa S, Bhatti S, Umar S, Bansal A, Sun W . Molecular Pathogenesis and Classification of Colorectal Carcinoma. Curr Colorectal Cancer Rep. 2020; 16(5):97-106. PMC: 7469945. DOI: 10.1007/s11888-020-00458-z. View

11.

Stanich P, Pearlman R . Hereditary or Not? Understanding Serrated Polyposis Syndrome. Curr Treat Options Gastroenterol. 2019; 17(4):692-701. DOI: 10.1007/s11938-019-00256-z. View

12.

Marmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi M . Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci. 2017; 18(1). PMC: 5297828. DOI: 10.3390/ijms18010197. View

13.

Pickard J, Zeng M, Caruso R, Nunez G . Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017; 279(1):70-89. PMC: 5657496. DOI: 10.1111/imr.12567. View

14.

Chen Y, Zhou J, Wang L . Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol. 2021; 11:625913. PMC: 8010197. DOI: 10.3389/fcimb.2021.625913. View

15.

Al Bander Z, Nitert M, Mousa A, Naderpoor N . The Gut Microbiota and Inflammation: An Overview. Int J Environ Res Public Health. 2020; 17(20). PMC: 7589951. DOI: 10.3390/ijerph17207618. View

16.

Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano G, Gasbarrini A . What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019; 7(1). PMC: 6351938. DOI: 10.3390/microorganisms7010014. View

17.

Gilbert J, Blaser M, Caporaso J, Jansson J, Lynch S, Knight R . Current understanding of the human microbiome. Nat Med. 2018; 24(4):392-400. PMC: 7043356. DOI: 10.1038/nm.4517. View

18.

Rodriguez J, Murphy K, Stanton C, Ross R, Kober O, Juge N . The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015; 26:26050. PMC: 4315782. DOI: 10.3402/mehd.v26.26050. View

19.

Schoultz I, Keita A . The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells. 2020; 9(8). PMC: 7463717. DOI: 10.3390/cells9081909. View

20.

Di Tommaso N, Gasbarrini A, Ponziani F . Intestinal Barrier in Human Health and Disease. Int J Environ Res Public Health. 2021; 18(23). PMC: 8657205. DOI: 10.3390/ijerph182312836. View